Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells

Ning Zhang1, Xiaohui Hua2, Huailu Tu1

  • 1Department of Environmental Medicine, New York University Grossman School of Medicine, 341 East 25th Street, New York, NY, 10010, USA.

Cancer Letters
|July 31, 2021
PubMed

Insights

Isoflavone (ISO) inhibits bladder cancer cell invasion by reducing Vimentin, a key marker of epithelial mesenchymal transition (EMT). This occurs through upregulation of METTL14 via the FOXO3a pathway, offering new therapeutic insights.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Epithelial mesenchymal transition (EMT) is crucial for cancer metastasis.
  • Isoflavone (ISO) is known to inhibit cancer cell invasion and stem-cell properties.
  • The effect of ISO on EMT markers remains largely unexplored.

Purpose of the Study:

  • To investigate the regulatory role of ISO on EMT in bladder cancer.
  • To determine if ISO affects EMT markers, leading to reduced migration and invasion.
  • To elucidate the molecular mechanisms underlying ISO's effects on bladder cancer cells.

Main Methods:

  • Utilized invasive bladder cancer cell lines (U5637 and T24T).
  • Assessed the protein and mRNA levels of EMT markers, specifically Vimentin.
  • Investigated the expression of METTL14 and the transcription factor FOXO3a.
  • Analyzed the regulatory pathways connecting ISO, FOXO3a, METTL14, and Vimentin.

Main Results:

  • ISO significantly inhibited Vimentin protein levels in bladder cancer cells.
  • ISO treatment led to increased expression of METTL14.
  • ISO upregulated METTL14 mRNA by activating the transcription factor FOXO3a.
  • These molecular changes correlated with reduced cancer cell invasion and migration.

Conclusions:

  • ISO effectively inhibits bladder cancer cell invasion by modulating EMT markers.
  • ISO upregulates METTL14 expression through the FOXO3a pathway, impacting Vimentin levels.
  • This study provides novel insights into the anti-metastatic potential of ISO via EMT regulation.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K